Ignite Creation Date:
2024-05-05 @ 10:58 PM
Last Modification Date:
2024-10-26 @ 10:26 AM
Study NCT ID:
NCT01223027
Status:
COMPLETED
Last Update Posted:
2015-12-07
First Post:
2010-09-30
Brief Title:
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-03
Start Date Type:
None
Primary Completion Date:
2014-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-06
Completion Date Type:
ACTUAL
First Submit Date:
2010-09-30
First Submit QC Date:
October 15 2010
Study First Post Date:
2010-10-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2015-11-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-11-05
Last Update Post Date:
2015-12-07
Last Update Post Date Type:
ESTIMATED